-transparent.png){kind=logo}
Much has been learnt over the past 80 years of the pathogenesis and management of hyperparathyroid bone disease in uraemia. Clinically it has changed from a rare disorder of childhood and adolescence to a common and difficult problem in patients maintained on dialysis programmes. Whereas effective treatments are now available for hyperparathyroid bone disease, these are not curative and there is clearly much more work to be done before a full understanding of its pathogenesis, and the best methods of treatment and prevention, can be reached.
Related Publications
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
August 1990,
Diabetes research (Edinburgh, Scotland),
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
January 1990,
Nephron,
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
January 1986,
Mineral and electrolyte metabolism,
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
January 1995,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
June 1976,
Nursing times,
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
November 1972,
British medical journal,
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
December 1972,
British medical journal,
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
November 1968,
The Indian journal of medical research,
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
October 1963,
The Quarterly journal of medicine,
T Cundy, and
N Hamdy, and
R Gray, and
B Jackson, and
J A Kanis
August 2013,
Clinical kidney journal,
